William V Walsh, MD

University of MassachusettsWorcester, Massachusetts - 01655 (508-865-1767) UMASS Memorial Cancer Center - ...Worcester, Massachusetts - 01655 (508-856-4225) |
- CLINICAL TRIALS 2
- CONDITIONS2
- INTERVENTIONS8
- SINCE2006

Pharmacodynamic Separation of Pemetrexed and Erlotinib as Second-line Therapy in Patients With Advanced Non-small Cell Lung Cancer (NSCLC)
May 2006 - May 2011

Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB Stage II or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
June 2007 - July 2015
Lung Neoplasms
Carcinoma, Non-Small-Cell Lung
Bevacizumab
Cisplatin
Docetaxel
Gemcitabine Hydrochloride
Pemetrexed Disodium
Pemetrexed
Pemetrexed And Erlotinib
Vinorelbine Ditartrate



